Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer
<b>Background</b>: Subtype classification for breast cancer (BC) patients is important for risk-stratification. Unfortunately, this parameter is not always able to discriminate between high- and low-risk diseases. Glutamate Carboxypeptidase-II (GCPII), also known as prostate-specific membrane antige...
Збережено в:
| Автори: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2026-03-01
|
| Серія: | Biomedicines |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2227-9059/14/3/628 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
